Protocol for AREST: Apixaban for Early Prevention of Recurrent Embolic Stroke and Hemorrhagic Transformation—A Randomized Controlled Trial of Early Anticoagulation After Acute Ischemic Stroke in Atrial Fibrillation

Background: Optimal timing to initiate anticoagulation after acute ischemic stroke (AIS) from atrial fibrillation (AF) is currently unknown. Compared to other stroke etiologies, AF typically provokes larger infarct volumes and greater concern of hemorrhagic transformation, so seminal randomized tria...

Descripción completa

Detalles Bibliográficos
Autores principales: Rose, David Z., Meriwether, John N., Fradley, Michael G., Renati, Swetha, Martin, Ryan C., Kasprowicz, Thomas, Patel, Aarti, Mokin, Maxim, Murtagh, Ryan, Kip, Kevin, Bozeman, Andrea C., McTigue, Tara, Hilker, Nicholas, Kirby, Bonnie, Wick, Natasha, Tran, Nhi, Burgin, W. Scott, Labovitz, Arthur J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6763567/
https://www.ncbi.nlm.nih.gov/pubmed/31620067
http://dx.doi.org/10.3389/fneur.2019.00975

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6763567/
https://www.ncbi.nlm.nih.gov/pubmed/31620067
http://dx.doi.org/10.3389/fneur.2019.00975

Ejemplares similares